SupplementDig
Advanced Supplement Search by Ingredient & Dose

Systane I-Caps AREDS 2 Chewable Tablets Berry Flavor by Alcon

🛒 Buy on Amazon

Supplement Facts

Serving Size: 2 Chewable Tablet(s), 1 time daily
Servings Per Container: 30
Amount Per Serving % Daily Value* (Adults and children 4 or more years of age)
Calories 20 Calorie(s) 1%
Calories 5 Calorie(s)

Carbohydrate 4 Gram(s) 1%
Sucrose 2 Gram(s)
Vitamin C (Ascorbic Acid, Sodium Ascorbate) 500 mg 840%
Vitamin E (D-Alpha-Tocopheryl Acetate) 400 IU 1340%
Zinc (Zinc Oxide) 25 mg 170%
Copper (Copper Citrate) 2 mg 100%
Lutein (Tagetes erecta) 10 mg
Zeaxanthin (Tagetes erecta) 2 mg

* Percent daily values (DV) are based on a diet of 2000 calories/day † Daily Value not established.
Other Ingredients: Dextrose, D-Mannitol, Bilberry fruit extract, Natural Flavors, Stearic Acid, Strawberry flavor, Raspberry flavor, Citric Acid, Blueberry flavor, Calcium Silicate, Silicon Dioxide, Sucralose, Maltodextrin, Gum Acacia, Vegetable Juice.

Statements

Suggested Use:

2 chewables per day

Warnings:

Contains: Milk, fish (cod, pollack, haddock, hake, cusk, redfish, sole, flounder).

Warnings: Do not use if safety seal under cap is broken or missing.

Do not use this product if you are allergic to milk or fish.

If you are taking prescription medications or are being treated for a medical condition, you should consult your healthcare professional before taking this (or any) dietary supplement.

Keep out of reach of children.

Higher levels of Zinc may cause an upset stomach.
Systane ICaps AREDS2 Formula contains only 25 mg of Zinc to minimize negative side effects without impacting performance.

Storage:

Store container at room temperature with the lid tightly closed.

Does Not Contain:

No added beta-carotene.

Other Information:

Age-related eye disease study 2
Contains ingredients clinically shown to support eye health in people with intermediate to advanced age-related macular degeneration (AMD)

Contains ingredients used in the Age-related Eye Disease Study 2 (AREDS2) conducted by the National Eye Institute to support eye heath in people with Age-related macular degeneration (AMD)

AREDS2 is a registered trademark of the United States Department of Health and Human Services (HHS).

Country of Origin: Canada

FDA Disclaimer:

This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Back to Search Results